Q32 Bio Inc. (LON:0T6G)
2.470
+0.019 (0.78%)
At close: Feb 21, 2025
Q32 Bio Revenue
Q32 Bio had revenue of $-14.66M USD in the twelve months ending September 30, 2024, down -224.35% year-over-year. In the year 2023, Q32 Bio had annual revenue of $-6.65M, down -200.00%.
Revenue (ttm)
$-14.66M
Revenue Growth
-224.35%
P/S Ratio
n/a
Revenue / Employee
$-396.27K
Employees
37
Market Cap
24.76M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | -6.65M | -13.30M | -200.00% |
Dec 31, 2022 | 6.65M | - | - |
Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQ32 Bio News
- 12 days ago - Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata - PRNewsWire
- 12 days ago - Sio Capital Management, LLC Acquires Significant Stake in Q32 Bio Inc - GuruFocus
- 18 days ago - Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 2 months ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 2 months ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 2 months ago - Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment - Investor's Business Daily
- 2 months ago - Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program - PRNewsWire
- 3 months ago - Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire